Cite

HARVARD Citation

    Iavarone, M. et al. (n.d.). Excellent 5-years survival for HBV cirrhotic patients developing a hepatocellular carcinoma during long-term analogs treatment. Digestive and liver disease. 50 (1), pp. 11-. [Online]. 
  
Back to record